Search
Gyre Therapeutics Inc
GYREAdd to Watchlist
5.650USD
-0.340-5.68%
Close 07-29 16:00（ET）Quotes delayed by 15 min
516.05MMarket Cap
LossP/E TTM
Gyre Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-29The current valuation score of Gyre Therapeutics Inc is 7.76, ranking 196 out of 384 in the Biotechnology & Medical Research industry. Its current P/E ratio is -80.43, which is -335.03% below the recent high of 189.05 and -32.45% above the recent low of -106.53.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.